Ubs Group Ag Coll Plant Biotechnologies LTD Transaction History
Ubs Group Ag
- $397 Billion
- Q1 2024
A detailed history of Ubs Group Ag transactions in Coll Plant Biotechnologies LTD stock. As of the latest transaction made, Ubs Group Ag holds 4,780 shares of CLGN stock, worth $23,756. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,780Holding current value
$23,756% of portfolio
0.0%Shares
11 transactions
Others Institutions Holding CLGN
# of Institutions
16Shares Held
1.88MCall Options Held
200Put Options Held
500-
Pinnacle Associates LTD530KShares$2.64 Million0.05% of portfolio
-
Investment Management Of Virginia LLC464KShares$2.31 Million0.63% of portfolio
-
Villere St Denis J & CO LLC367KShares$1.82 Million0.17% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD315KShares$1.57 Million3.45% of portfolio
-
Brown Advisory Inc120KShares$594,0930.0% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $55.1M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...